Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Qiagen N.V. (QGEN)

Qiagen N.V. (QGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,336,073
  • Shares Outstanding, K 225,509
  • Annual Sales, $ 1,502 M
  • Annual Income, $ 190,380 K
  • 60-Month Beta 0.99
  • Price/Sales 6.26
  • Price/Cash Flow 16.97
  • Price/Book 3.81

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.44
  • Number of Estimates 6
  • High Estimate 0.45
  • Low Estimate 0.43
  • Prior Year 0.40
  • Growth Rate Est. (year over year) +10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.04 +29.21%
on 11/12/19
43.16 -4.08%
on 12/02/19
+9.03 (+27.90%)
since 11/11/19
3-Month
25.04 +65.34%
on 10/09/19
43.16 -4.08%
on 12/02/19
+7.57 (+22.38%)
since 09/11/19
52-Week
25.04 +65.34%
on 10/09/19
43.16 -4.08%
on 12/02/19
+6.36 (+18.15%)
since 12/11/18

Most Recent Stories

More News
28.2% Return Seen to Date on SmarTrend Qiagen Nv Call (QGEN)

SmarTrend identified an Uptrend for Qiagen Nv (NYSE:QGEN) on November 12th, 2019 at $32.35. In approximately 4 weeks, Qiagen Nv has returned 28.19% as of today's recent price of $41.47.

QGEN : 41.40 (-0.67%)
OSMT vs. QGEN: Which Stock Should Value Investors Buy Now?

OSMT vs. QGEN: Which Stock Is the Better Value Option?

OSMT : 7.09 (-7.92%)
QGEN : 41.40 (-0.67%)
Qiagen Nv Falls 2.02% on Heavy Volume: Watch For Potential Rebound

Qiagen Nv (NYSE:QGEN) traded in a range yesterday that spanned from a low of $42.01 to a high of $42.29. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $42.19 on...

QGEN : 41.40 (-0.67%)
Look for Shares of Qiagen Nv to Potentially Rebound after Yesterday's 2.02% Sell Off

Qiagen Nv (NYSE:QGEN) traded in a range yesterday that spanned from a low of $42.01 to a high of $42.29. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $42.19 on...

QGEN : 41.40 (-0.67%)
Qiagen Nv Up 31.2% Since SmarTrend Uptrend Call (QGEN)

SmarTrend identified an Uptrend for Qiagen Nv (NYSE:QGEN) on November 12th, 2019 at $32.35. In approximately 3 weeks, Qiagen Nv has returned 31.16% as of today's recent price of $42.43.

QGEN : 41.40 (-0.67%)
QIAGEN and DiaSorin Get FDA Approval for LIAISON QFT-Plus

QIAGEN (QGEN) and DiaSorin begin the commercial launch of the QFT-Plus test in the United States, following the FDA clearance.

HAE : 117.55 (+0.01%)
RMD : 150.48 (+1.01%)
QGEN : 41.40 (-0.67%)
EYE : 30.63 (+1.76%)
Look for Shares of Qiagen Nv to Potentially Pullback after Yesterday's 1.39% Rise

Qiagen Nv (NYSE:QGEN) traded in a range yesterday that spanned from a low of $42.19 to a high of $42.48. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $41.91...

QGEN : 41.40 (-0.67%)
Watch for Qiagen Nv to Potentially Pullback After Gaining 1.39% Yesterday

Qiagen Nv (NYSE:QGEN) traded in a range yesterday that spanned from a low of $42.19 to a high of $42.48. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $41.91...

QGEN : 41.40 (-0.67%)
ROSEN, A GLOBAL LAW FIRM, Continues to Investigate Securities Claims Against QIAGEN N.V. - QGEN

Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Qiagen N.V. (NYSE: QGEN) resulting from allegations that Qiagen may...

QGEN : 41.40 (-0.67%)
After Yesterday's Rally of 1.69% Shares Could Potentially Pullback

Qiagen Nv (NYSE:QGEN) traded in a range yesterday that spanned from a low of $41.57 to a high of $41.79. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $41.35...

QGEN : 41.40 (-0.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade QGEN with:

Business Summary

Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.

See More

Key Turning Points

2nd Resistance Point 41.70
1st Resistance Point 41.55
Last Price 41.40
1st Support Level 41.25
2nd Support Level 41.10

See More

52-Week High 43.16
Last Price 41.40
Fibonacci 61.8% 36.24
Fibonacci 50% 34.10
Fibonacci 38.2% 31.96
52-Week Low 25.04

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar